Notice of Privacy Incident
Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: June 25, 2008

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Duac CS	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Evoclin Foam	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Glumetza	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Cimzia	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Pristiq	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Treximet	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Bystolic	New Drug Initial Review	Removed from Agenda	Prior Approval Required
Luvox CR	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Voltaren Gel	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Iquix	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval requirement removed
Sanctura XR	New Drug Appeal	Require Prior Approval	Prior Approval Required
Vyvanse	New Drug Appeal	Require Prior Approval	Prior Approval Required
Combigan	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval requirement removed
Vusion	New Drug Appeal	Require Prior Approval	Prior Approval Required
Strattera	PDL Appeal	Remove Prior Approval Requirement	Prior Approval Required
Lovaza	PDL Appeal	Require Prior Approval	Prior Approval Required
Fazaclo	PDL Appeal	Remove Prior Approval Requirement	Prior Approval requirement removed

Footer